BR112014029260A2 - medicamento para um ser humano ou um animal não humano, medicamento para anestesia geral, medicamento para a prevenção e/ou alívio de um déficit neurológico induzido por anestésico, método para parar o mesmo, uso de um anestésico geral, uso de uma anestésico geral e hidrogênio para a produção de um medicamento e método para prevenir e/ou aliviar um déficit neurológico induzido por anestésico - Google Patents
medicamento para um ser humano ou um animal não humano, medicamento para anestesia geral, medicamento para a prevenção e/ou alívio de um déficit neurológico induzido por anestésico, método para parar o mesmo, uso de um anestésico geral, uso de uma anestésico geral e hidrogênio para a produção de um medicamento e método para prevenir e/ou aliviar um déficit neurológico induzido por anestésicoInfo
- Publication number
- BR112014029260A2 BR112014029260A2 BR112014029260A BR112014029260A BR112014029260A2 BR 112014029260 A2 BR112014029260 A2 BR 112014029260A2 BR 112014029260 A BR112014029260 A BR 112014029260A BR 112014029260 A BR112014029260 A BR 112014029260A BR 112014029260 A2 BR112014029260 A2 BR 112014029260A2
- Authority
- BR
- Brazil
- Prior art keywords
- anesthetic
- medicine
- general
- neurological deficit
- induced neurological
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012125535 | 2012-05-31 | ||
| PCT/JP2013/065094 WO2013180240A1 (ja) | 2012-05-31 | 2013-05-30 | 全身麻酔薬と、水素とを組み合わせてなる、医薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014029260A2 true BR112014029260A2 (pt) | 2017-06-27 |
Family
ID=49673427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014029260A BR112014029260A2 (pt) | 2012-05-31 | 2013-05-30 | medicamento para um ser humano ou um animal não humano, medicamento para anestesia geral, medicamento para a prevenção e/ou alívio de um déficit neurológico induzido por anestésico, método para parar o mesmo, uso de um anestésico geral, uso de uma anestésico geral e hidrogênio para a produção de um medicamento e método para prevenir e/ou aliviar um déficit neurológico induzido por anestésico |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20150079197A1 (enExample) |
| EP (1) | EP2857026A4 (enExample) |
| JP (1) | JP6168420B2 (enExample) |
| KR (1) | KR20150018832A (enExample) |
| CN (1) | CN104394873A (enExample) |
| AU (1) | AU2013268366A1 (enExample) |
| BR (1) | BR112014029260A2 (enExample) |
| CA (1) | CA2874579A1 (enExample) |
| HK (1) | HK1205450A1 (enExample) |
| IL (1) | IL235718A0 (enExample) |
| IN (1) | IN2014MN02090A (enExample) |
| MX (1) | MX2014014543A (enExample) |
| NZ (1) | NZ701553A (enExample) |
| RU (1) | RU2014152690A (enExample) |
| SG (1) | SG11201407489TA (enExample) |
| WO (1) | WO2013180240A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6253029B2 (ja) * | 2015-01-21 | 2017-12-27 | 大陽日酸株式会社 | 麻酔器用取付キット |
| US20180338995A1 (en) * | 2017-05-23 | 2018-11-29 | Perricone Hydrogen Water Company, Llc | Systems and methods for treatments using hydrogen and/or noble gases |
| US11129848B2 (en) * | 2017-08-08 | 2021-09-28 | Perricone Hydrogen Water Company, Llc | Medication enhancement using hydrogen |
| US20210222174A1 (en) * | 2018-06-29 | 2021-07-22 | John Mansell | Compositions and methods for the treatment of anesthesia-induced neurotoxicity |
| US11123365B2 (en) | 2019-11-18 | 2021-09-21 | Perricone Hydrogen Water Company, Llc | Compositions comprising palmitoylethanolamide and hydrogen water, and methods thereof |
| JP7019910B2 (ja) * | 2020-07-21 | 2022-02-16 | ＭｉＺ株式会社 | 薬の副作用、薬の副作用に関連する症状、および／または、治療に伴う副作用を予防および／または改善するための組成物 |
| CN117861037A (zh) * | 2022-10-11 | 2024-04-12 | 上海氢医医疗科技有限公司 | 氢气吸入治疗自闭症 |
| CN119303200A (zh) * | 2024-12-17 | 2025-01-14 | 山东百多安医疗器械股份有限公司 | 一种可以释放氢气减少神经损伤的麻醉机 |
-
2013
- 2013-05-30 MX MX2014014543A patent/MX2014014543A/es unknown
- 2013-05-30 WO PCT/JP2013/065094 patent/WO2013180240A1/ja not_active Ceased
- 2013-05-30 CN CN201380028933.5A patent/CN104394873A/zh active Pending
- 2013-05-30 AU AU2013268366A patent/AU2013268366A1/en not_active Abandoned
- 2013-05-30 NZ NZ701553A patent/NZ701553A/en not_active IP Right Cessation
- 2013-05-30 US US14/397,229 patent/US20150079197A1/en not_active Abandoned
- 2013-05-30 JP JP2014518736A patent/JP6168420B2/ja not_active Expired - Fee Related
- 2013-05-30 BR BR112014029260A patent/BR112014029260A2/pt not_active Application Discontinuation
- 2013-05-30 KR KR20147035945A patent/KR20150018832A/ko not_active Withdrawn
- 2013-05-30 CA CA2874579A patent/CA2874579A1/en not_active Abandoned
- 2013-05-30 RU RU2014152690A patent/RU2014152690A/ru unknown
- 2013-05-30 IN IN2090MUN2014 patent/IN2014MN02090A/en unknown
- 2013-05-30 HK HK15103729.5A patent/HK1205450A1/en unknown
- 2013-05-30 EP EP13796554.7A patent/EP2857026A4/en not_active Withdrawn
- 2013-05-30 SG SG11201407489TA patent/SG11201407489TA/en unknown
-
2014
- 2014-11-16 IL IL235718A patent/IL235718A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150018832A (ko) | 2015-02-24 |
| CA2874579A1 (en) | 2013-12-05 |
| WO2013180240A1 (ja) | 2013-12-05 |
| EP2857026A4 (en) | 2015-11-04 |
| US20150079197A1 (en) | 2015-03-19 |
| JP6168420B2 (ja) | 2017-07-26 |
| SG11201407489TA (en) | 2014-12-30 |
| MX2014014543A (es) | 2015-06-05 |
| IN2014MN02090A (enExample) | 2015-09-04 |
| NZ701553A (en) | 2016-06-24 |
| RU2014152690A (ru) | 2016-07-20 |
| IL235718A0 (en) | 2015-01-29 |
| EP2857026A1 (en) | 2015-04-08 |
| AU2013268366A1 (en) | 2015-03-19 |
| JPWO2013180240A1 (ja) | 2016-01-21 |
| HK1205450A1 (en) | 2015-12-18 |
| CN104394873A (zh) | 2015-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014029260A2 (pt) | medicamento para um ser humano ou um animal não humano, medicamento para anestesia geral, medicamento para a prevenção e/ou alívio de um déficit neurológico induzido por anestésico, método para parar o mesmo, uso de um anestésico geral, uso de uma anestésico geral e hidrogênio para a produção de um medicamento e método para prevenir e/ou aliviar um déficit neurológico induzido por anestésico | |
| EP2958486A4 (en) | DEVICE FOR ENABLING PATIENT SICKNESS TESTS AND TREATMENT INDIVIDUAL MANAGEMENT, AND SYSTEM WITH THE DEVICE FOR MANAGING HEALTH CARE FOR A PATIENT | |
| HUE053409T2 (hu) | Ortopédiai szék a gerincbetegségek kezelésére és megelõzésére | |
| IL216467B (en) | Pharmaceutical compositions deliverable from a metered dose inhaler comprising glycopyrrolate or formoterol and their use in treatment of pulmonary diseases | |
| SG11201501075RA (en) | Medical devices for blood reflux prevention and methods of use | |
| MX2019003249A (es) | Diagnostico, prevencion y tratamiento de enfermedades de la articulacion. | |
| BR112015003332A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
| BR112015003398A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
| IL232251B (en) | Pharmaceutical combination for use in the treatment of type 2 diabetes patients | |
| PL2464342T3 (pl) | Formulacje farmaceutyczne do zapobiegania niewłaściwemu użyciu leków medycznych | |
| EP2877175A4 (en) | USE OF CSE INHIBITORS FOR THE TREATMENT OF SKIN INJURY OR SLEEPING BREATHING | |
| GB2496800B (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition | |
| PT2582366E (pt) | Combinação terapêutica para o tratamento da dor | |
| IL222890A0 (en) | Medicaments for the treatment of il-1beta related conditions | |
| ZA201502290B (en) | 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and ist associated disorders | |
| BR112014030406A8 (pt) | combinação de canabidiol fitocanabinoide com hipotermia terapêutica, e, uso de uma combinação | |
| HUS2000020I1 (hu) | Ciklezonid a légúti betegségek kezelésére lovaknál | |
| IL235852A0 (en) | A pharmaceutical preparation for the treatment and prevention of psychological, behavioral and cognitive disorders | |
| BR112014025737A2 (pt) | método para administrar um agente terapêutico, método para prevenir a entrada de um agente terapêutico, método para modular a velocidade de liberação de um agente terapêutico, agente terapêutico, formas de dosagem, método de tratamento de uma doença e kit de partes | |
| PH12016500863A1 (en) | Tetracyclic autotaxin inhibitors | |
| PL2774991T3 (pl) | System dostarczania leków do stosowania w leczeniu lub diagnostyce zaburzeń neurologicznych | |
| HUE038580T2 (hu) | Hatóanyag bejuttató rendszer neurológiai rendellenességek kezelésében, vagy diagnózisában való felhasználásra | |
| SI2874600T1 (sl) | Farmacevtski sestavek za zdravljenje hripavosti ali bolečin v grlu | |
| EP2442657A4 (en) | USE OF R-BAMBUTEROL AS INHALED MEDICAMENT AND COMBINATION THERAPIES FOR THE TREATMENT OF RESPIRATORY DISEASES | |
| GB2499687B (en) | Medical device for the treatment of a patient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |